報價延遲最少15分鐘:2026/03/09 23:28 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.53 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.72/6.50
|
|
企業價值
10.34B
|
| 資產負債 |
|
每股賬面淨值
2.89
|
| 現金流量 |
|
現金流量率
0.41
|
| 損益表 |
|
收益
6.22B
|
|
每股收益
23.63
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio. |
